Physician profile
James E Kendrick
NPI 1164450508
$3,116.21
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,295 · 2020: $815 · 2021: $516 · 2022: $206 · 2023: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $284.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $763.38 | 2019-2022 | |
| Medical Device Business Services, INC. | $750.00 | 2020 | |
| Biom'Up France Sas | $321.41 | 2021 | |
| Ethicon US, LLC | $222.86 | 2019-2023 | Enseal |
| Conmed Corporation | $152.34 | 2019 | |
| Clovis Oncology, INC. | $137.25 | 2019 | |
| Stryker Corporation | $125.42 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $124.44 | 2019 | |
| Tesaro, INC. | $114.99 | 2019 | |
| Integra Lifesciences Corporation | $110.42 | 2023 | Biofix, Biodoptix, Medihoney |
| Abbvie INC. | $110.00 | 2019 | |
| Myriad Genetic Laboratories, INC. | $103.87 | 2023 | Precisetumor |
| Genentech USA, INC. | $64.49 | 2019 | |
| Ethicon INC. | $15.34 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kendrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.